Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabis for Pain in Sickle Cell Disease
NCT01771731Phase 2Completed
- Sponsor
- University of California, San Francisco
- Start
- Aug 2014
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabis in sickle cell disease (SCD), sponsored by University of California, San Francisco. Started Aug 2014; status: completed.
02
Drugs
cannabis
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT01771731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01771731.